100 likes | 115 Views
Heidelberg Pharma AG (FSE: WL6) announces that it has successfully raised approximately EUR 14.4 million in gross proceeds through a private placement via an accelerated book-building transaction. Heidelberg Pharma issued 2,820,961
E N D
Press release Distribution Service New York-based MRD Lighting, a major vendor to the international cruise industry, is developing ultraviolet lighting prototypes to combat airborne and surface-transmitted viruses aboard ships.
The company, which has consistently innovated in providing a Press release Distribution Service wide array of solutions to cruise lines,
Ultraviolet technology has long been used in various settings to kill bacteria and viruses MRD has already contacted senior cruise industry executives with this concept and there is significant attention being paid to how UVC lighting fixtures can be deployed widely and cost-effectively throughout vessels.
MRD is looking to provide UVC light disinfection to cruise lines while maintaining the architectural aesthetics of a space,
UVC lighting fixtures can be deployed widely and cost-effectively throughout vessels. UVC light (200-280 nanometers) RNA, resulting in the inactivation
sanitization utilizing MRD proposed solutions. “This is not a new idea, but what we bring to the table is a large experience base in prototyping, refining, and scaling production of systems tailored for specific spaces and uses,” said Riotto. “Our existing relationships in the cruise industry are significant. We want to add UVC technology to our offerings.”
CONTACT Us… Skype - shalabh.mishraTelegram - shalabhmishraWhatsapp- +919212306116Email - shalabh.mishra@gmail.comMobile - +919212306116